APA
Freedman R. A., Gelman R. S., Anders C. K., Melisko M. E., Parsons H. A., Cropp A. M., Silvestri K., Cotter C. M., Componeschi K. P., Marte J. M., Connolly R. M., Moy B., Van Poznak C. H., Blackwell K. L., Puhalla S. L., Jankowitz R. C., Smith K. L., Ibrahim N., Moynihan T. J., O'Sullivan C. C., Nangia J., Niravath P., Tung N., Pohlmann P. R., Burns R., Rimawi M. F., Krop I. E., Wolff A. C., Winer E. P. & Lin N. U. (20200331). TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Freedman Rachel A, Gelman Rebecca S, Anders Carey K, Melisko Michelle E, Parsons Heather A, Cropp Anne M, Silvestri Kelly, Cotter Christine M, Componeschi Kathryn P, Marte Juan M, Connolly Roisin M, Moy Beverly, Van Poznak Catherine H, Blackwell Kimberly L, Puhalla Shannon L, Jankowitz Rachel C, Smith Karen L, Ibrahim Nuhad, Moynihan Timothy J, O'Sullivan Ciara C, Nangia Julie, Niravath Polly, Tung Nadine, Pohlmann Paula R, Burns Robyn, Rimawi Mothaffar F, Krop Ian E, Wolff Antonio C, Winer Eric P and Lin Nancy U. 20200331. TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Freedman R. A., Gelman R. S., Anders C. K., Melisko M. E., Parsons H. A., Cropp A. M., Silvestri K., Cotter C. M., Componeschi K. P., Marte J. M., Connolly R. M., Moy B., Van Poznak C. H., Blackwell K. L., Puhalla S. L., Jankowitz R. C., Smith K. L., Ibrahim N., Moynihan T. J., O'Sullivan C. C., Nangia J., Niravath P., Tung N., Pohlmann P. R., Burns R., Rimawi M. F., Krop I. E., Wolff A. C., Winer E. P. and Lin N. U. (20200331). TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Freedman Rachel A, Gelman Rebecca S, Anders Carey K, Melisko Michelle E, Parsons Heather A, Cropp Anne M, Silvestri Kelly, Cotter Christine M, Componeschi Kathryn P, Marte Juan M, Connolly Roisin M, Moy Beverly, Van Poznak Catherine H, Blackwell Kimberly L, Puhalla Shannon L, Jankowitz Rachel C, Smith Karen L, Ibrahim Nuhad, Moynihan Timothy J, O'Sullivan Ciara C, Nangia Julie, Niravath Polly, Tung Nadine, Pohlmann Paula R, Burns Robyn, Rimawi Mothaffar F, Krop Ian E, Wolff Antonio C, Winer Eric P and Lin Nancy U. TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20200331.